Page 3 - Punit Dhillon News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Punit dhillon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Punit Dhillon Today - Breaking & Trending Today

Skye Bioscience (SKYE) Announces $50.25M Private Placement

Skye Bioscience (SKYE) Announces $50.25M Private Placement
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Piper Sandler , Punit Dhillon , Exchange Commission , Oppenheimer Co , Skye Bioscience Inc , Skye Bioscience , Ally Bridge Group , Sphera Healthcare , Altium Capital , Driehaus Capital Management , Securities Act ,

Breaking Biotech Funding News - Skye Bioscience (OTCQB: SKYE) Announces $50.25 Million Private Placement Equity Financing

Breaking Biotech Funding News - Skye Bioscience (OTCQB: SKYE) Announces $50.25 Million Private Placement Equity Financing ....

United States , San Diego , Piper Sandler , Punit Dhillon , Mike Moyer , Exchange Commission , Newsfile Corp Investorideas , Oppenheimer Co , Newswire Skye Bioscience Inc , Skye Bioscience Inc , Newsfile Corp , Skye Bioscience , Ally Bridge Group , Sphera Healthcare , Altium Capital , Driehaus Capital Management , Securities Act , Sci Advisors , Risk Factors , Investor Ideas , Skye Bioscience , Illion Private Placement Equity Financing ,

Skye Bioscience Announces $50.25 Million Private Placement Equity Financing

Skye Bioscience, Inc. , a clinical stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid. ....

San Diego , United States , Piper Sandler , Mike Moyer , Punit Dhillon , Oppenheimer Co , California Newsfile Corp , Exchange Commission , Skye Bioscience Inc , Ally Bridge Group , Sphera Healthcare , Altium Capital , Driehaus Capital Management , Securities Act , Skye Bioscience , Sci Advisors , Risk Factors ,

Skye Bioscience Receives IND Clearance for Phase 2 Clinical Trial of Nimacimab in Obesity and Chronic Kidney Disease

Skye Bioscience, Inc. , a pharmaceutical company developing drugs targeting the endocannabinoid system, has received clearance of its Investigational New Drug application with the U.S. Food and Drug. ....

San Francisco , United States , Mike Moyer , Punit Dhillon , Skye Bioscience , Tu Diep , Skye Bioscience Inc , Exchange Commission , Drug Administration , California Newsfile Corp , Investigational New Drug , Chief Development Officer , Endocannabinoid System , Sci Advisors , Risk Factors ,

Skye Bioscience expands into booming obesity market with CB1 inhibitor

Skye Bioscience has announced its plans to develop nimacimab, the company’s monoclonal antibody recently acquired from Bird Rock Bio, for weight loss and the treatment of obesity. ....

Tu Diep , Punit Dhillon , Drug Administration , Investigational New Drug , Bio Developments , Markets Amp Regulations , Emerging Markets , Kidney Disease ,